⚡ Flash Summary
First Elite Capital Modaraba reported its financial results for the quarter ended September 30, 2025. The company experienced an operating loss of (1,783,506) Rupees, compared to a loss of (222,163) Rupees in the same period last year. Consequently, the loss per certificate was (0.17) Rupees, significantly worse than the (0.03) Rupees reported in the previous year. The board did not recommend any cash dividend, bonus certificates, or right certificates.
Signal: SELL 📉
Strength: 8/10
Sentiment: NEGATIVE
Time Horizon: SHORT_TERM
📌 Key Takeaways
- ❌ The company reported a significant operating loss of (1,783,506) Rupees for the quarter ended September 30, 2025.
- 📉 This is a considerable increase from the operating loss of (222,163) Rupees in the same quarter last year.
- 📉 Loss per certificate worsened to (0.17) Rupees from (0.03) Rupees year-over-year.
- ⛔ No cash dividend was recommended by the board.
- ⛔ No bonus certificates were recommended.
- ⛔ No right certificates were recommended.
- ⬆️ Income from ijarah financing increased to 10,809,976 Rupees from 9,222,845 Rupees last year.
- ⬇️ Return on investments significantly decreased to 373,911 Rupees from 1,231,075 Rupees.
- ⬆️ Depreciation of assets leased out increased to 8,359,928 Rupees from 6,697,145 Rupees.
- ⬆️ Administrative and general expenses rose slightly to 4,262,423 Rupees from 4,069,766 Rupees.
- ⬇️ Net cash inflow from operating activities decreased to 20,880,701 Rupees from 9,403,932 Rupees.
- ⬇️ Net assets increased slightly to 138,839,045 Rupees from 136,691,709 Rupees.
- ➡️ Issued, subscribed, and paid-up capital remained constant at 113,400,000 Rupees.
- 😔 The company’s financial performance has deteriorated compared to the same period last year.
🎯 Investment Thesis
Due to the significant operating loss, negative EPS, and lack of dividend, a SELL recommendation is appropriate. There is no visibility of profit. The target price is below the accounting book value. Time horizon is short term.
View Original PDF
Disclaimer: AI-generated analysis. Not financial advice.
